Quetiapine-Induced Neuroleptic Malignant Syndrome

Prim Care Companion CNS Disord. 2023 Mar 23;25(2):22cr03332. doi: 10.4088/PCC.22cr03332.

Authors

Rodrigo Saraiva^{1

2

3}, Beatriz Côrte-Real^{1

2}, Catarina Cordeiro^{1

2}, Maria João Gonçalves¹, Manuela Abreu^{1

2}, Ricardo Coentre^{1

2}

Affiliations

¹ Psychiatry and Mental Health Department, Centro Hopitalar Universitário Lisboa Norte, Lisbon, Portugal.
² Clínica de Psiquiatria e Psicologia Médica, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
³ Corresponding author: Rodrigo Saraiva, MD, Estrada de Benfica 446, 6° Direito, Lisbon, Portugal (saraiva.rodrigo@campus.ul.pt).

PMID: 36963375
DOI: 10.4088/PCC.22cr03332

No abstract available

MeSH terms

Antipsychotic Agents* / adverse effects
Humans
Neuroleptic Malignant Syndrome* / diagnosis
Neuroleptic Malignant Syndrome* / etiology
Quetiapine Fumarate / adverse effects

Substances

Quetiapine Fumarate
Antipsychotic Agents